These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10877141)

  • 1. Absence of azathioprine hypersensitivity after administration of its active metabolite 6-mercaptopurine.
    Schmitt K; Pfeiffer U; Stiehrle HE; Thuermann PA
    Acta Derm Venereol; 2000; 80(2):147-8. PubMed ID: 10877141
    [No Abstract]   [Full Text] [Related]  

  • 2. Azathioprine hypersensitivity: report of two cases and review of the literature.
    Sinico RA; Sabadini E; Borlandelli S; Cosci P; Di Toma L; Imbasciati E
    J Nephrol; 2003; 16(2):272-6. PubMed ID: 12768076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy.
    Baker DE
    Rev Gastroenterol Disord; 2003; 3(3):150-7. PubMed ID: 14502119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythema nodosum-like eruption as a manifestation of azathioprine hypersensitivity in patients with inflammatory bowel disease.
    de Fonclare AL; Khosrotehrani K; Aractingi S; Duriez P; Cosnes J; Beaugerie L
    Arch Dermatol; 2007 Jun; 143(6):744-8. PubMed ID: 17576940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ulcerative colitis. Chronic active course].
    Dignass AU; Herrlinger K; Schölmerich J
    Z Gastroenterol; 2004 Sep; 42(9):1006-10. PubMed ID: 15455274
    [No Abstract]   [Full Text] [Related]  

  • 6. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
    Dubinsky MC; Feldman EJ; Abreu MT; Targan SR; Vasiliauskas EA
    Am J Gastroenterol; 2003 May; 98(5):1058-63. PubMed ID: 12809828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of Crohn disease recurrence with azathioprine--for whom, how long?].
    Koop I; Schreiber S
    Z Gastroenterol; 1997 Jan; 35(1):47-8. PubMed ID: 9123958
    [No Abstract]   [Full Text] [Related]  

  • 8. Azathioprine-associated hypersensitivity reaction in a patient with Churg Strauss vasculitis.
    Lehmann P; Fleck M; Schoelmerich J; Haerle P
    J Clin Rheumatol; 2010 Aug; 16(5):242-3. PubMed ID: 20661072
    [No Abstract]   [Full Text] [Related]  

  • 9. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
    Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azathioprine pancreatitis in inflammatory bowel disease and successful subsequent treatment with mercaptopurine.
    Alexander S; Dowling D
    Intern Med J; 2005 Sep; 35(9):570-1. PubMed ID: 16105163
    [No Abstract]   [Full Text] [Related]  

  • 11. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiopurine therapy: when to start and when to stop.
    McGovern DP; Travis SP
    Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):219-23. PubMed ID: 12610314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azathioprine hypersensitivity presenting as neutrophilic dermatosis and erythema nodosum.
    Cheraghi N; Yasuda M; Deng A; Mailhot J
    Cutis; 2016 Jul; 98(1):E7-9. PubMed ID: 27529720
    [No Abstract]   [Full Text] [Related]  

  • 14. Leucocytoclastic vasculitis in a patient with azathioprine hypersensitivity.
    Beckett CG; Hill P; Hine KR
    Postgrad Med J; 1996 Jul; 72(849):437-8. PubMed ID: 8935609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
    Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
    Hepatogastroenterology; 2006; 53(69):399-404. PubMed ID: 16795981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three hospital admissions in 9 days to diagnose azathioprine hypersensitivity in a patient with Crohn's disease.
    Mookherjee S; Narayanan M; Uchiyama T; Wentworth KL
    Am J Ther; 2015; 22(2):e28-32. PubMed ID: 23782763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When is too much enough?
    Mayer L
    Gastroenterology; 2006 Apr; 130(4):1352-4. PubMed ID: 16618427
    [No Abstract]   [Full Text] [Related]  

  • 18. The cutaneous and systemic manifestations of azathioprine hypersensitivity syndrome.
    Bidinger JJ; Sky K; Battafarano DF; Henning JS
    J Am Acad Dermatol; 2011 Jul; 65(1):184-91. PubMed ID: 21496951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine-induced hypersensitivity hepatitis: tolerance to 6-mercaptopurine.
    Andrejic J; Rojas-Balcazar J; Dennis M; Berkelhammer C
    Inflamm Bowel Dis; 2010 Nov; 16(11):1828-9. PubMed ID: 20196148
    [No Abstract]   [Full Text] [Related]  

  • 20. Azathioprine: when less is more.
    Duley JA; Florin TH
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1317-9. PubMed ID: 18853992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.